FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

SUPPL AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)